ARCHIVES

NCCTG Plans To Conduct Phase II Study Of Brostallicin Plus Cisplatin For mTNBC

This article is from The Cancer Letter archive.

Vol. 33 No. 4 | April 30, 2010

Download PDF Visit The Full Archive

Related Articles

Guest Editorial: Andrew Vickers on PSA Skepticism, Rational and Irrational

October 10, 2014

Schwetz Replaces Koski As HHS Human Research Protections Director

February 7, 2003

Steckel Urges AACI to seek Increase In Core Funding

July 17, 1981

NCI Advisory Group, Other Cancer Meetings

January 2, 1981

Phase II Study Cohort Fails To Overcome Erlotinib Resistance

April 26, 2013

Pittsburgh, Norris Win Bristol-Myers Unrestricted Grants

April 19, 1991